Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-24 @ 4:20 PM
NCT ID:
NCT07183566
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (≥18 years) with a confirmed diagnosis of HCC based on AASLD or EASL criteria.
* Patients deemed unresectable by the multidisciplinary tumor board.
* Patients scheduled for TACE as the primary locoregional therapy.
* Preserved liver function (Child-Pugh class A or B).
* Adequate renal function to permit contrast-enhanced CT.
Exclusion Criteria:
* Patients with extrahepatic metastases or portal vein thrombosis.
* Patients with contraindications to iodinated contrast or TACE.
* Patients with severe comorbid illness that precludes participation.
* Patients refuse to provide informed consent.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07183566
Study Brief:
Protocol Section:
NCT07183566